APA (7th ed.) Citation

Lee, J., Yu, S. H., Kim, S. R., Ahn, K. J., Song, K., Lee, I., . . . Lee, M. (2024). Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial. Diabetes & metabolism journal, 48(4), 730-739. https://doi.org/10.4093/dmj.2023.0077

Chicago Style (17th ed.) Citation

Lee, Jie-Eun, et al. "Efficacy and Safety of Metformin and Atorvastatin Combination Therapy Vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial." Diabetes & Metabolism Journal 48, no. 4 (2024): 730-739. https://doi.org/10.4093/dmj.2023.0077.

MLA (9th ed.) Citation

Lee, Jie-Eun, et al. "Efficacy and Safety of Metformin and Atorvastatin Combination Therapy Vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial." Diabetes & Metabolism Journal, vol. 48, no. 4, 2024, pp. 730-739, https://doi.org/10.4093/dmj.2023.0077.